Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT03737604 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

TAP Blocks With Ropivacaine Continuous Infusion Catheters vs Single Dose Liposomal Bupivicaine After Kidney Transplant

StatusActive, Not Recruiting
PhasePhase 4
Started
View on ClinicalTrials.gov ↗
Record status
This record was last updated July 6, 2026 (before its estimated September 12, 2026 completion). Its status may not reflect the trial's current state.

Record History

  1. Trial status changed: Recruiting → Active, Not Recruiting
    • Primary and study completion pushed from Jun 12, 2026 to Sep 12, 2026
    • Site details revised
    v11
  2. Primary and study completion dates: Jun 12, 2025 to Jun 12, 2026v10
  3. Primary completion date: Dec 31, 2024 to Jun 12, 2025
    • Study completion date: Jul 1, 2025 to Jun 12, 2025
    v9
  4. Re-verified, no change to tracked fieldsv8
  5. Primary completion date: Dec 1, 2022 to Dec 31, 2024
    • Study completion date: Jan 1, 2023 to Jul 1, 2025
    v7
Show 5 earlier versionsHide 5 earlier versions
  1. Primary completion date: Jun 1, 2022 to Dec 1, 2022
    • Study completion date: Oct 1, 2022 to Jan 1, 2023
    v6
  2. Study Status, Referencesv5
  3. Primary completion date: Jun 1, 2021 to Jun 1, 2022
    • Study completion date: Oct 1, 2021 to Oct 1, 2022
    v4
  4. Primary completion date: Jun 1, 2020 to Jun 1, 2021
    • Study completion date: Oct 1, 2020 to Oct 1, 2021
    v3
  5. Primary completion date: Oct 4, 2019 to Jun 1, 2020
    • Study completion date: Apr 1, 2020 to Oct 1, 2020
    v2
  1. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
This study is a comparison of the analgesic efficacy of transversus abdominis plane (TAP) blocks with ropivacaine bolus plus continuous ropivacaine infusion via catheters versus single shot TAP blocks with liposomal bupivacaine.
Trial Details
NCT Number NCT03737604
Lead Sponsor University of California, Davis
Conditions
(from sponsor)		 Transplant;Failure,Kidney, Pain, Postoperative
Related terms Postoperative Pain
Enrollment 200 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov